Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Institutional buyer or Fund @ $5.50 US
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bigboyoneon Aug 25, 2016 3:14pm
107 Views
Post# 25177396

RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 US

RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 USGoldenDI -
I disagree, you are basing the pullback on one parameter?Being overbought?
I have seen overbought stocks go on for two weeks or more. 
Explain to me the Volume? The Outstanding shares vs. Common Shares?  750k to Mil + shares Every day, traded in  the last 2-3 weeks?
Even with "Crossing" and Double Counts" in the total, it doesnt compute.
There are 38 Mil in Common  which is all that is supposed to be in play..If I am wrong , tell me? With another 30 in Outstanding, which includes Treasury, that is not in play.
We have traded over 15 mil, who has that stock?, who is selling? and why?
The little guy isnt.
 What I see is, after (Yosprala) approval (if it happens) the company wants to keep the lid on, to about Pozen the conversion to Aralez price. $6.50 a share.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities